Advances in biomanufacturing and medical applications of three-dimensional-printed organoids: A review
International Journal of Bioprinting · 10.06.2025 · 11 (4) · 66
DOI: 10.36922/ijb025190184 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Bioprinting, online erschienen am 10.06.2025. Verfasst von Lingzi Liao und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
The emergence of organoid technology has bridged critical gaps between conventional two-dimensional cell cultures and in vivo systems by offering self-organized three-dimensional (3D) microtissues that recapitulate organ-specific architecture, cellular heterogeneity, and functional dynamics. However, traditional organoid models face inherent limitations in structural precision, scalability, and physiological relevance, particularly in replicating vascular networks, mechanical microenvironments, and multicellular interactions. Recent advancements in 3D bioprinting have enabled unprecedented spatial control over cellular and extracellular matrix organization, unlocking new frontiers in engineering organoids with enhanced biomimicry and functionality. This review systematically examines the integration of bioprinting technologies with organoid science, spanning biomaterial innovations, vascularization strategies, and dynamic microenvironmental cues that drive functional maturation. By synthesizing interdisciplinary advances in stem cell biology, materials science, and computational modeling, the work highlights applications across regenerative medicine, disease pathophysiology, and personalized drug screening. Key challenges, including immunogenicity, long-term stability, and clinical scalability, are critically evaluated alongside emerging solutions such as four-dimensional bioprinting, organ-on-chip integration, and artificial intelligence-driven bioink optimization. Through a comprehensive analysis of bioprinted organoids for physiology and 3D disease modeling, this review aims to establish a translational roadmap for leveraging spatially programmed organoids to address unmet clinical needs, revolutionize therapeutic development, and advance precision medicine.
Zitieren
APA
Liao, L., Feng, Q., Shan, X., Cai, Z., & Xie, S. (2025). Advances in biomanufacturing and medical applications of three-dimensional-printed organoids: A review. International Journal of Bioprinting, 11(4), 66. https://doi.org/10.36922/ijb025190184
Vancouver
Liao L, Feng Q, Shan X, Cai Z, Xie S. Advances in biomanufacturing and medical applications of three-dimensional-printed organoids: A review. International Journal of Bioprinting. 2025;11(4):66. doi:10.36922/ijb025190184
BibTeX
@article{Liao2025,
author = {Liao, Lingzi and Feng, Qiushi and Shan, Xiaofeng and Cai, Zhigang and Xie, Shang},
title = {Advances in biomanufacturing and medical applications of three-dimensional-printed organoids: A review},
journal = {International Journal of Bioprinting},
year = {2025},
volume = {11},
number = {4},
pages = {66},
doi = {10.36922/ijb025190184}
}
EUVIMED